Scienta Lab Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$54.2K
- Investors
-
12
Scienta Lab General Information
Description
Developer of an AI-driven immunology research platform intended to predict human immune response and improve drug development outcomes. The company's platform provides multi-omic data integration, target prioritization, translational risk assessment, and clinical prediction capabilities, enabling pharmaceutical and biotechnology teams to make informed decisions across discovery, preclinical, and early clinical development stages.
Contact Information
Website
www.scientalab.comCorporate Office
- 1 Parvis de Notre Dame
- 75004 Paris
- France
Corporate Office
- 1 Parvis de Notre Dame
- 75004 Paris
- France
Scienta Lab Timeline
Scienta Lab Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Accelerator/Incubator | 03-Apr-2025 | $54.2K | Completed | Generating Revenue | ||
| 7. Accelerator/Incubator | 15-Nov-2023 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 26-Sep-2023 | Completed | Generating Revenue | |||
| 5. Seed Round | 12-May-2023 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 08-Dec-2022 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2022 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2021 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
Scienta Lab Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Scienta Lab Patents
Scienta Lab Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026150007-A1 | Device for generating an artificial intelligence system of prediction of an effect of a drug on a patient, device for predicting an effect of a drug on a patient | Pending | 08-Jan-2025 | ||
| EP-4740221-A1 | Method and device for stratifying patients for diagnosis, prognosis and response to treatment | Pending | 05-Jul-2023 | ||
| WO-2025008522-A1 | Method and device for stratifying patients for diagnosis, prognosis and response to treatment | Inactive | 05-Jul-2023 | ||
| FR-3150898-A1 | Method and device for stratifying subjects for diagnosis, prognosis and response to treatment | Pending | 05-Jul-2023 | G16H50/50 |
Scienta Lab Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Scienta Lab Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| EIT Health | Accelerator/Incubator | |||
| Station F | Accelerator/Incubator | |||
| d'lle de France | Government | |||
| ByTheTower | Venture Capital | Minority | ||
| CentraleSupélec | Accelerator/Incubator | Minority |
Scienta Lab FAQs
-
When was Scienta Lab founded?
Scienta Lab was founded in 2021.
-
Where is Scienta Lab headquartered?
Scienta Lab is headquartered in Paris, France.
-
What is the size of Scienta Lab?
Scienta Lab has 17 total employees.
-
What industry is Scienta Lab in?
Scienta Lab’s primary industry is Biotechnology.
-
Is Scienta Lab a private or public company?
Scienta Lab is a Private company.
-
What is Scienta Lab’s current revenue?
The current revenue for Scienta Lab is .
-
How much funding has Scienta Lab raised over time?
Scienta Lab has raised $5M.
-
Who are Scienta Lab’s investors?
EIT Health, Station F, d'lle de France, ByTheTower, and CentraleSupélec are 5 of 12 investors who have invested in Scienta Lab.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
